BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5063552)

  • 1. [Effect of oxygen and Persantin (dipyridamole) on coronary circulation].
    Saito T; Hirano T
    Masui; 1972 Feb; 21(2):120-4. PubMed ID: 5063552
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
    Saito T
    Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proceedings: Coronary steal phenomenon in intracoronary infusion of adenosine, nitroglycerine, persantin, intensain and nifedipine].
    Meyer U; Schiffer W; Schulz FW; Raff WK
    Z Kardiol; 1974; 0(Suppl 1):33. PubMed ID: 4215252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interaction of adenosine, dipyridamole, aminophylline and ether anesthesia in coronary and pulmonary circulation].
    Kettler D; Bretschneider HJ; Hellige G; Hensel I; Martel J; Reploh HD
    Pflugers Arch; 1972; 332():Suppl 332:R48. PubMed ID: 5066033
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of dipyridamole (Persantin) in reducing the infarct size following experimental coronary occlusion.
    Watanabe T; Shintani F; Fu L; Kato K; Koyama S
    Jpn Heart J; 1972 Nov; 13(6):512-20. PubMed ID: 4539940
    [No Abstract]   [Full Text] [Related]  

  • 6. [The comparative studies on the influence of persantin on the coronary circulation in dogs and rabbits].
    Filczewski M; Oledzka K; Nowicka J
    Acta Physiol Pol; 1969; 20(1):155-63. PubMed ID: 5793303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of nitroglycerin, nifedipine and dipyridamole on the left coronary blood flow patterns and the myocardial blood flow in the left ventricle (author's transl)].
    Hirano T; Maeda T; Morishita T; Shinohara S; Kawata F; Kinjo M
    Kokyu To Junkan; 1980 Sep; 28(9):1021-9. PubMed ID: 6782632
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of Persantin on the coronary circulation].
    Brugger A; Lluch S; Marco V; Esplugues J
    Rev Clin Esp; 1965 Sep; 98(6):401-4. PubMed ID: 5865268
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of dipyridamol (Persantin) on myocardial adenosine metabolism.
    Kübler W; Spieckermann PG; Bretschneider HJ
    J Mol Cell Cardiol; 1970 Mar; 1(1):23-38. PubMed ID: 5520352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of dipyridamole (Persantin) administered per os on coronary circulation in unanesthetized dogs].
    Laubie M
    Therapie; 1971; 26(1):197-209. PubMed ID: 5554764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coronary steal with the use of dipyridamole in patients with obstructive coronary disease].
    Marchant E; Pichard A; Casanegra P
    Rev Med Chil; 1984 Apr; 112(4):342-9. PubMed ID: 6484360
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interaction of coronary-active compounds and anti-inflammatory drugs on the coronary vascular system (author's transl)].
    Jacobi H; Jentzsch KR; Lüdtke W; Schwarz H
    Arzneimittelforschung; 1981; 31(10):1704-10. PubMed ID: 7198446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of persantin to reduce microaggregation in the pump oxygenation.
    Rittenhouse EA; Hessel EA; Ito CS; Merendino KA
    Surg Forum; 1970; 21():142-4. PubMed ID: 5514711
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative local blood-flow changes in the insufficiently supplied dog myocardium, measured by means of the heat-clearance method.
    Benzing H; Wahl SH; Bender HP; Rabe M
    Bibl Anat; 1973; 11():139-44. PubMed ID: 4274970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myocardial protection and coronary artery circulation (1)].
    Hirano T
    Kokyu To Junkan; 1980 Jun; 28(6):590. PubMed ID: 7414113
    [No Abstract]   [Full Text] [Related]  

  • 16. Difference in site and time course of coronary dilating effects of trapidil, nitroglycerin and dipyridamole in anesthetized dogs.
    Noguchi K; Tomoike H; Ootsubo H; Sakai K; Nakamura M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):809-14. PubMed ID: 6795344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic study on application of Persantin for anesthesia].
    Saito T; Okazaki K; Hirano T; Matsuzaki T; Wakisaka K
    Masui; 1966 Apr; 15(4):322-7. PubMed ID: 6008695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oxygen pressure and oxygen consumption in coronary venous blood as well as the changes of the arterio-coronary venous O2 content difference and the coronary circulation with high doses of 2,6-(diethanolamino)-4,-8-dipiperidinopyrimido -(5,4-d) pyrimidine (Persantin)].
    Doll E; Keul J; Brechtel
    Z Kreislaufforsch; 1966 Nov; 55(10):1076-97. PubMed ID: 5998956
    [No Abstract]   [Full Text] [Related]  

  • 19. [DEVELOPMENT OF CORONARY COLLATERAL CIRCULATION BY CHRONIC ORAL PERSANTIN THERAPY].
    MEESMANN W; BUSCH G; BRAASCH W; BACHMANN GW
    Med Welt; 1964 May; 20():1106-11. PubMed ID: 14221265
    [No Abstract]   [Full Text] [Related]  

  • 20. Blunted response of myocardial perfusion to dipyridamole in older adults (revisited).
    Buxton DB
    J Nucl Med; 1995 Jun; 36(6):1137-9. PubMed ID: 7769440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.